GUIDED THERAPEUTICS: Submits Clinical Study Protocol to U.S. FDA for LuViva® Advanced Cervical Scan
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced that it had submitted its protocol to FDA for a clinical study to support marketing of the LuViva® Advanced Cervical Scan in the United States.